Clinical Performance of Adhesive Systems Containing HEMA and 10-MDP in Non Carious Cervical Lesions

May 17, 2022 updated by: Cecy Martins Silva, Universidade Federal do Para

Clinical Performance of Adhesive Systems Containing HEMA and 10-MDP in Non Carious Cervical Lesions - A Two Years Randomized Double Blind Study

The objective of this randomized, double-blind clinical trial is to evaluate the clinical performance of non-carious cervicals adhesive restorations using three self-etching adhesives containing HEMA and 10-MDP monomers.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Sixty teeth (n = 20 for each group) will be randomized into 03 groups: Clearfil SE (contains MDP and HEMA), Optibond All-inOne (contains HEMA) and Prime and Bond Universal (contains neither monomer) dispatch). Restorations will be performed by a single operator, and no mechanical retention will be performed under the cavity. After 6, 12 and 24 months, the restorations will be evaluated by two calibrated examiners, using modified USPHS criteria for retention (kappa = 1.00) and adaptation / marginal color (kappa = 0.81), and the results will be analysed by Fisher and Kruskal-Wallis, respectively. An intragroup analysis will be performed using the Cochran test (for retention) and Wilcoxon (for marginal adaptation / staining).

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pará
      • Belém, Pará, Brazil, 66075-110
        • Para's Federal University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Good oral hygiene
  • Absence of periodontal disease
  • Presence of at least 02 non-carious cervical lesions

Exclusion Criteria:

  • Presence of non-carious cervical lesion in non-vital teeth
  • Occlusal instability
  • Presence of orthodontic appliance
  • Presence of removable partial dental prosthesis
  • High risk of caries (presence of three or more active caries lesions)
  • Xerostomia
  • Bruxism
  • Patients allergic to base materials monomers
  • Patients who do not accept the project conditions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Clearfil SE
Group containing 10-MDP and HEMA monomers
All patients will receive adhesive composite resin restorations. There will be 3 groups (different adhesives): Clearfil SE, Optibond All-in-One and Prime & Bond Universal.
Other Names:
  • composite resin restorations with Clearfil SE adhesive
  • composite resin restorations with Optibond All-in-One adhesive
  • composite resin restorations with Prime & Bond Universal adhesive
Active Comparator: Optibond All-in-One
Group containing HEMA monomer
All patients will receive adhesive composite resin restorations. There will be 3 groups (different adhesives): Clearfil SE, Optibond All-in-One and Prime & Bond Universal.
Other Names:
  • composite resin restorations with Clearfil SE adhesive
  • composite resin restorations with Optibond All-in-One adhesive
  • composite resin restorations with Prime & Bond Universal adhesive
Active Comparator: Prime & Bond Universal
Control Group containing other monomers
All patients will receive adhesive composite resin restorations. There will be 3 groups (different adhesives): Clearfil SE, Optibond All-in-One and Prime & Bond Universal.
Other Names:
  • composite resin restorations with Clearfil SE adhesive
  • composite resin restorations with Optibond All-in-One adhesive
  • composite resin restorations with Prime & Bond Universal adhesive

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Retention rate of restoration
Time Frame: 01 year

The retention rate will be assessed following the USPHS (United States Public Health) guidelines with the following classifications (acronyms):

Alpha = retained. Charlie = mobility or loss.

01 year
Retention rate of restoration
Time Frame: 02 years

The retention rate will be assessed following the USPHS (United States Public Health) guidelines with the following classifications (acronyms):

Alpha = retained. Charlie = mobility or loss.

02 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Marginal staining rate of restoration
Time Frame: 01 year

The marginal staining rate will be assessed following the USPHS (United States Public Health) guidelines with the following classifications (acronyms):

Alpha = no staining. Bravo = superficial staining (localized or generalized). Charlie = deep staining (localized or generalized).

01 year
Marginal staining rate of restoration
Time Frame: 02 years

The marginal staining rate will be assessed following the USPHS (United States Public Health) guidelines with the following classifications (acronyms):

Alpha = no staining. Bravo = superficial staining (localized or generalized). Charlie = deep staining (localized or generalized).

02 years
Marginal Adaptation rate of restoration
Time Frame: 01 year

The marginal adaptation rate will be assessed following the USPHS (United States Public Health) guidelines with the following classifications (acronyms):

Alpha = no visible evidence of a crack along the edge, the explorer will not penetrate.

Bravo = visible evidence of a crack along the margin, dentin unexposed, clinically acceptable.

Charlie = explorer penetrates the crack, dentin exposed, clinically unacceptable.

01 year
Marginal Adaptation rate of restoration
Time Frame: 02 years

The marginal adaptation rate will be assessed following the USPHS (United States Public Health) guidelines with the following classifications (acronyms):

Alpha = no visible evidence of a crack along the edge, the explorer will not penetrate.

Bravo = visible evidence of a crack along the margin, dentin unexposed, clinically acceptable.

Charlie = explorer penetrates the crack, dentin exposed, clinically unacceptable.

02 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative sensitivity rate of restoration
Time Frame: 01 year
present or absent
01 year
Postoperative sensitivity rate of restoration
Time Frame: 02 years
present or absent
02 years
Secondary caries rate of restoration
Time Frame: 01 year
present or absent
01 year
Secondary caries rate of restoration
Time Frame: 02 years
present or absent
02 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Roberta Oliveira, Msc, Federal University of Pará
  • Study Chair: Brennda De Paula, Msc, Federal University of Pará
  • Study Director: Cecy Silva, PhD, Federal University of Pará

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 12, 2020

Primary Completion (Actual)

February 12, 2021

Study Completion (Actual)

February 12, 2022

Study Registration Dates

First Submitted

February 5, 2021

First Submitted That Met QC Criteria

February 11, 2021

First Posted (Actual)

February 16, 2021

Study Record Updates

Last Update Posted (Actual)

May 24, 2022

Last Update Submitted That Met QC Criteria

May 17, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UFPara

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Non Carious Cervical Lesion

Clinical Trials on composite resin restoration

Subscribe